Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antimicrobial Therapy for Infections Due to Pseudomonas Aeruginosa With Difficult-to-treat Resistance: a Real-world, Prospective, Multicenter Cohort Study

NCT06738771 is registered in ClinicalTrials.gov with Centre Hospitalier Régional d'Orléans as lead sponsor.

NCT NCT06738771
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06738771 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antimicrobial Therapy for Infections Due to Pseudomonas Aeruginosa With Difficult-to-treat Resistance: a Real-world, Prospective, Multicenter Cohort Study
Lead sponsor
Centre Hospitalier Régional d'Orléans
Phase
Observational
Overall status
Recruiting
Start date
March 11, 2025
Completion date
January 31, 2027
Enrollment
600 (estimated)
Sites
48

Conditions

As the registry lists them; a condition with its own page is linked.

antibacterial agents, beta-lactam antibiotics, drug resistance, multiple, bacterial, prognosis, pseudomonas aeruginosa, pseudomonas infections